Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC

Clinical trial NCT04594694 · TERMINATED

Trial details

NCT number: NCT04594694
Sponsor: Intercept Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Biliary Cholangitis

Start date: 2019-10-02
Primary completion: 2025-10-14
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.